Table 5.
A deep insight exploring correlation with geographical, clinical features in patients experiencing hospital readmission and death
| Readmission (n = 28) | p value | Mortality (n = 13) | p value | |
|---|---|---|---|---|
| Provenance from ‘COVID-19 red zones’, n. (%) No Yes |
25 (89.3%) 3 (10.7%) |
0.02 |
4 (30.8%) 9 (69.2%) |
0.001 |
| Risk hospital area Low Medium High |
3 (10.7%) 12 (42.9%) 13 (46.4%) |
0.41 |
0 (0%) 3 (23.1%) 10 (76.9%) |
0.02 |
| Admission to COVID-19-free facility, n. (%) No Yes |
18 (64.2%) 10 (35.8%) |
0.36 |
7 (53.8%) 6 (46.2%) |
0.20 |
| Nasopharyngeal swab at hospitalization, n. (%) No Yes |
24 (85.7%) 4 (14.3%) |
0.01 |
12 (92.3%) 1 (7.7%) |
0.01 |
| Postoperative surgical complications, n. (%) No Yes |
21 (75%) 7 (25%) |
0.001 |
11 (84.6%) 2 (15.4%) |
0.03 |
| Postoperative medical complications, n. (%) No Yes |
19 (67.9%) 9 (32.1%) |
0.01 |
8 (61.5%) 5 (38.5%) |
0.01 |
| Fever in the 30 days following discharge, n (%) No Yes |
17 (60.7%) 11 (39.3%) |
0.001 |
9 (69.2%) 4 (30.8%) |
0.001 |
| Respiratory symptoms in the 30 days following discharge, n (%) No Yes |
23 (82.1%) 5 (17.9%) |
0.01 |
8 (61.5%) 5 (38.5%) |
0.001 |
n – number